Dick’s Sporting Goods stands by full-year guidance — even with tariffs looming

Dick’s Sporting Goods stands by full-year guidance — even with tariffs looming


A sign is posted in front of a Dick’s Sporting Goods store on September 04, 2024 in Daly City, California. 

Justin Sullivan | Getty Images

Dick’s Sporting Goods said Wednesday it’s standing by its full-year guidance, which includes the expected impact from all tariffs currently in effect.

The sporting goods giant said it’s expecting earnings per share to be between $13.80 and $14.40 in fiscal 2025 — in line with the $14.29 that analysts had expected, according to LSEG. 

It’s expecting revenue to be between $13.6 billion and $13.9 billion, which is also in line with expectations of $13.9 billion, according to LSEG.

“We are reaffirming our 2025 outlook, which reflects our strong start to the year and confidence in our strategies and operational strength while still acknowledging the dynamic macroeconomic environment,” CEO Lauren Hobart said in a news release. “Our performance demonstrates the momentum and strength of our long-term strategies and the consistency of our execution.” 

Here’s how the company performed in its first fiscal quarter compared with what Wall Street was anticipating, based on a survey of analysts by LSEG:

  • Earnings per share: $3.37 adjusted. It wasn’t immediately clear if the results were comparable to estimates.
  • Revenue: $3.17 billion vs. $3.13 billion 

The company’s reported net income for the three-month period that ended May 3 was $264 million, or $3.24 per share, compared with $275 million, or $3.30 per share, a year earlier. Excluding one-time items related to its acquisition of Foot Locker, Dick’s posted earnings per share of $3.37. 

Sales rose to $3.17 billion, up about 5% from $3.02 billion a year earlier. 

For most investors, Dick’s results won’t come as a surprise because it preannounced some of its numbers about two weeks ago when it unveiled plans to acquire its longtime rival Foot Locker for $2.4 billion. So far, Dick’s has seen a mix of reactions to the proposed acquisition.

On one hand, Dick’s acquisition of Foot Locker will allow it to enter international markets for the first time and reach a customer that’s crucial to the sneaker market and doesn’t typically shop in the retailer’s stores. On the other hand, Dick’s is acquiring a business that’s been struggling for years and some aren’t sure needs to exist due to its overlap with other wholesalers and the rise of brands selling directly to consumers. 

While shares of Foot Locker initially soared more than 80% after the deal was announced, shares of Dick’s fell about 15%. 

The deal is expected to close in the second half of fiscal 2025 and, for now, Dick’s outlook doesn’t include acquisition-related costs or results from the acquisition. 

In the first full fiscal year post-close, Dick’s expects the transaction to be accretive to earnings and deliver between $100 million and $125 million in cost synergies. 

Don’t miss these insights from CNBC PRO



Source

Spotify teams up with Peloton to launch global fitness content hub
Business

Spotify teams up with Peloton to launch global fitness content hub

Spotify is increasing its push beyond music and podcasts as the company on Monday announced a new fitness category partnership with Peloton Interactive. The deal will make more than 1,400 Peloton classes available to Spotify Premium subscribers across most of its global markets, embedding fitness content directly into Spotify’s existing audio and video ecosystem, according […]

Read More
Wall Street expects solid Q1 results for GM, as Ford and Stellantis try to gain traction
Business

Wall Street expects solid Q1 results for GM, as Ford and Stellantis try to gain traction

Traders work on the floor at the New York Stock Exchange in New York City, March 27, 2025. Brendan McDermid | Reuters DETROIT — As America’s largest automakers prepare to report first-quarter earnings results this week amid rising oil and commodity costs due to the Iran war, they find themselves traversing different terrains. General Motors […]

Read More
Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial
Business

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

Intellia Therapeutics, building exterior and company sign, Cambridge, Massachusetts, USA. Spencer Grant | Universal Images Group | Getty Images Intellia Therapeutics said its Crispr-based treatment for a rare swelling condition met its goals in a late-stage trial, marking a milestone for the field of gene editing and putting the company on track to seek approval […]

Read More